Antimicrobial therapy and aerobic bacteriologic culture patterns in canine intensive care unit patients: 74 dogs (January-June 2006)

Journal of Veterinary Emergency and Critical Care

Volumn 19, Issue 5, 2009, Pages 489-495

  Black, Dorothy M ^a,b   Rankin, Shelley C ^b   King, Lesley G ^b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antimicrobial surveillance; Infectious disease; Multidrug resistance

Indexed keywords

ANTIINFECTIVE AGENT;

AEROBIC BACTERIUM; ANIMAL; ANIMAL DISEASE; ARTICLE; BACTERIAL INFECTION; DOG; DOG DISEASE; DRUG EFFECT; FEMALE; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE; RETROSPECTIVE STUDY;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA, AEROBIC; BACTERIAL INFECTIONS; BACTERIOLOGICAL TECHNIQUES; DOG DISEASES; DOGS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES;

ACINETOBACTER BAUMANNII; ANIMALIA; BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; ESCHERICHIA COLI; STAPHYLOCOCCUS INTERMEDIUS;

EID: 70350474747     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.2009.00463.x     Document Type: Article

References (31)

1. Neu HC. The crisis in antibiotic resistance. Science 1992 257 (5073) : 1064 1073.
2. Appelbaum PC. MRSA - the tip of the iceberg. Clin Micro Infect 2006 12 (s2) : 3 10.
3. Hooper D. Emerging mechanisms of fluoroquinolone resistance. Emerg Infect Dis 2001 7 (2) : 337 341.
4. Kollef MH. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001 134 : 298 314.
5. Degoricija VSM, Legac A, Gradiser M, et al. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy. Croat Med J 2006 47 : 385 397.
6. Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial areatment of anfections: a risk factor for hospital mortality among critically ill patients. Chest 1999 115 (2) : 462 474.
7. Hyle EP, Lipworth AD, Zaoutis TE, et al. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum {beta}-lactamase-producing Enterobacteriaceae: variability by site of infection. Arch Intern Med 2005 165 (12) : 1375 1380.
8. Lautenbach E, Metlay JP, Bilker WB, et al. Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy. Clin Infect Dis 2005 41 (7) : 923 929.
9. Fridkin SK SC, Edwards JR, Pryor ER, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Clin Infect Dis 1999 29 : 245 252.
10. Willemsen I, Groenhuijzen A, Bogaers D, et al. Appropriateness of antimicrobial therapy measured by repeated prevalence surveys. Antimicrob Agents Chemother 2007 51 (3) : 864 867.
11. Lautenbach E, Larosa LA, Kasbekar N, et al. Fluoroquinolone utilization in the emergency departments of academic medical centers: prevalence of, and risk factors for, inappropriate use. Arch Intern Med 2003 163 (5) : 601 605.
12. Kollef MH, Vlasnik JON, Sharpless L, et al. Scheduled change of antibiotic classes. a strategy to decrease the incidence of ventilator- associated pneumonia. Am J Respir Crit Care Med 1997 156 (4) : 1040 1048.
13. Allegranzi B, Luzzati R, Luzzani A, et al. Impact of antibiotic changes in empirical therapy on antimicrobial resistance in intensive care unit-acquired infections. J Hosp Infect 2002 52 (2) : 136 140.
14. Apisarnthanarak A, Danchaivijitr S, Khawcharoenporn T, et al. Effectiveness of education and an antibiotic-control program in a tertiary care hospital in Thailand. Clin Infect Dis 2006 42 (6) : 768 775.
15. Gruson D, Hilbert G, Vargas F, et al. Rotation and restricted use of antibiotics in a medical intensive care unit. impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria. Am J Respir Crit Care Med 2000 162 (3) : 837 843.
16. Zahar JR, Rioux C, Girou E, et al. Inappropriate prescribing of aminoglycosides: risk factors and impact of an antibiotic control team. J Antimicrob Chemother 2006 58 (3) : 651 656.
17. Martinez JA, Nicolas JM, Marco F, et al. Comparison of antimicrobial cycling and mixing strategies in two medical intensive care units. Crit Care Med 2006 34 : 329 336.
18. Holso K, Rantala M, Lillas A, et al. Prescribing antimicrobial agents for dogs and cats via university pharmacies in Finland - patterns and quality of information. Acta Vet Scand 2005 46 (1-2) : 87 93.
19. Prescott J, Hanna W, Reid-Smith R, et al. Antimicrobial drug use and resistance in dogs. Can Vet J 2002 43 : 107 116.
20. Weese JS. Investigation of antimicrobial use and the impact of antimicrobial use guidelines in a small animal veterinary teaching hospital. J Am Vet Med Assoc 2006 228 (4) : 553 558.
21. Kluytmans-VandenBergh J, Klytmans J, Voss A. Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO). Infection 2005 33 : 309 313.
22. Ogeer-Gyles JSMK, Boerlin P. Nosocomial infections and antimicrobial resistance in critical care medicine. J Vet Emerg Crit Care 2005 16 (1) : 1 18.
23. Weber D, Raasch R, Rutala W. Nosocomial infections in the ICU. The growing importance of antibiotic-resistant pathogens. Chest 1999 115 : 42S 41S.
24. Emori T, Gaynes R. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993 6 (4) : 428 442.
25. Kollef M, Fraser V. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001 134 : 298 314.
26. Hirsh D, Jang S. Antimicrobial susceptibility of selected infectious bacterial agents obtained from dogs. J Am Anim Hosp Assoc 1994 30 : 487 494.
27. Cooke C, Singer R, Jang S. Enrofloxacin resistance in Escherichia coli isolated from dogs with urinary tract infections. J Am Vet Med Assoc 2002 220 (2) : 190 192.
28. Cohn L, Gary A, Fales W, et al. Trends in fluoroquinolone resistance of bacteria isolated from canine urinary tracts. J Vet Diagn Invest 2003 15 (4) : 338 343.
29. Richards M, Edwards J, Culver D, et al. Nosocomial infections in medical intensive care units in the United States. Crit Care Med 1999 27 (5) : 887 892. (Pubitemid 29266004)
30. Lipsitch M, Samore M. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis 2002 8 (4) : 347 354.
31. Trott D, Filippich L, Bensink J, et al. Canine model for investigating the impact of oral enrofloxacin on commensal coliforms and colonization with multidrug-resistant Escherichia coli. J Med Microbiol 2004 53 : 439 443.